These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21965035)

  • 1. [Urinary peptides and calcium oxalate nephrolithiasis, a combined approach: MALDI-TOF mass spectrometry and MicroBCA Protein Assay].
    Vittori M; D'Addessi A; Sacco E; Inzitari R; Fanali C; Totaro A; Bassi P
    Urologia; 2011; 78(3):227-32. PubMed ID: 21965035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium oxalate nephrolithiasis: urinary "medium size peptides"analysis using MALDI-TOF mass spectrometry.
    D'Addessi A; Bongiovanni L; Vittori M; Fanali C; Foschi N; Castagnola M; Bassi PF
    Arch Ital Urol Androl; 2010 Sep; 82(3):140-4. PubMed ID: 21121430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen alpha chain precursor and apolipoprotein A-I in urine as biomarkers for noninvasive diagnosis of calcium oxalate nephrolithiasis: a proteomics study.
    Zhu W; Liu M; Wang GC; Peng B; Yan Y; Che JP; Ma QW; Yao XD; Zheng JH
    Biomed Res Int; 2014; 2014():415651. PubMed ID: 25147800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of 3' vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis.
    Mossetti G; Rendina D; Viceconti R; Manno G; Guadagno V; Strazzullo P; Nunziata V
    Nephrol Dial Transplant; 2004 Sep; 19(9):2259-65. PubMed ID: 15213319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of Tamm-Horsfall protein glycans in kidney stone formers using novel techniques.
    Argade S; Chen T; Shaw T; Berecz Z; Shi W; Choudhury B; Parsons CL; Sur RL
    Urolithiasis; 2015 Aug; 43(4):303-12. PubMed ID: 25935139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus.
    Hartman C; Friedlander JI; Moreira DM; Elsamra SE; Smith AD; Okeke Z
    BJU Int; 2015 Apr; 115(4):619-24. PubMed ID: 24823472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of urine sodium on urine risk factors for calcium oxalate nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    J Urol; 2009 Nov; 182(5):2330-3. PubMed ID: 19758639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental determination of multiple thermodynamic and kinetic risk factors for nephrolithiasis in the urine of healthy controls and calcium oxalate stone formers: does a universal discriminator exist?
    Rodgers AL; Webber D; Hibberd B
    Urolithiasis; 2015 Nov; 43(6):479-87. PubMed ID: 26198547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.
    Mushtaq S; Siddiqui AA; Naqvi ZA; Rattani A; Talati J; Palmberg C; Shafqat J
    Clin Chim Acta; 2007 Sep; 384(1-2):41-7. PubMed ID: 17610860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of ambient temperature, humidity and season of year on urine composition in patients with nephrolithiasis.
    Eisner BH; Sheth S; Herrick B; Pais VM; Sawyer M; Miller N; Hurd KJ; Humphreys MR
    BJU Int; 2012 Dec; 110(11 Pt C):E1014-7. PubMed ID: 22578009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated With the Lower Prevalence of Nephrolithiasis in Children Compared With Adults.
    Grases F; Rodriguez A; Costa-Bauza A; Saez-Torres C; Rodrigo D; Gómez C; Mir-Perello C; Frontera G
    Urology; 2015 Sep; 86(3):587-92. PubMed ID: 26144339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary oxalate and calcium oxalate nephrolithiasis.
    Khan SR; Glenton PA; Byer KJ
    J Urol; 2007 Nov; 178(5):2191-6. PubMed ID: 17870111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National multi-institutional cooperative on urolithiasis in children: Age is a significant predictor of urine abnormalities.
    Cambareri GM; Kovacevic L; Bayne AP; Giel D; Corbett S; Schurtz E; Sukhu T; Chiang G
    J Pediatr Urol; 2015 Aug; 11(4):218-23. PubMed ID: 26119451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis.
    Duffey BG; Pedro RN; Makhlouf A; Kriedberg C; Stessman M; Hinck B; Ikramuddin S; Kellogg T; Slusarek B; Monga M
    J Am Coll Surg; 2008 Jun; 206(6):1145-53. PubMed ID: 18501812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.
    Terracciano R; Pasqua L; Casadonte F; Frascà S; Preianò M; Falcone D; Savino R
    Bioconjug Chem; 2009 May; 20(5):913-23. PubMed ID: 19338374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
    Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
    J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.